Last reviewed · How we verify

NCT05051215

Gut Microbiota and Nonpuerperal Mastitis

Status unknown Last updated 21 September 2021
What this trial tests

trial in Microbiota in 100 participants. Status unknown.

Timeline
15 August 2021
Primary endpoint
15 August 2023
15 August 2024

Quick facts

Lead sponsorFirst Affiliated Hospital of Harbin Medical University
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment100
Start date15 August 2021
Primary completion15 August 2023
Estimated completion15 August 2024
Sites1 location across China

Conditions studied

Sponsor

First Affiliated Hospital of Harbin Medical University

Who can join

Adults 18 to 65, female only, with Microbiota. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Nonpuerperal mastitis (NPM), mainly including Plasma cell mastitis (PCM) and Granulomatous mastitis (GM), which clinical presentation is an accessible and painful breast mass accompanied by skin redness and swelling, nipple retraction and fistula formation . Much progress has been made in exploring the etiology and pathogenesis of NPM, while the exact etiology remains unknown, NPM is thought to arise from interactions between genetic susceptibility factors, epigenetic effects, and various environmental factors. While microbiota as an environment factor to some inflammatory and autoimmune diseases accept widespread attention, if gut microbiota also as a risk factor for NPM, it is worthy to be considered.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Microbiota

Currently open trials in the same condition.

Other First Affiliated Hospital of Harbin Medical University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05051215.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing